Study Summary
This research study is studying Chimeric Antigen Receptor (CAR)-37 T Cells (CAR-37 T Cells) for treating people with relapsed or refractory CD37+ hematologic malignancies and to understand the side effects when treated with CAR-37 T Cells. \- Chimeric Antigen Receptor (CAR)-37 T Cells (CAR-37 T Cells) is an investigational treatment
Want to learn more about this trial?
Request More InfoInterventions
CAR-37 T cellsBIOLOGICAL
CAR-37 is an investigational treatment that uses the participant own immune cells, called T cells, to try to kill the cancerous cells
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Massachusetts General Hospital Cancer Center | Boston | Massachusetts | United States |